These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links. Wathieu H; Issa NT; Mohandoss M; Byers SW; Dakshanamurthy S Comb Chem High Throughput Screen; 2017; 20(3):193-207. PubMed ID: 28024464 [TBL] [Abstract][Full Text] [Related]
3. Identification of genes and pathways involved in kidney renal clear cell carcinoma. Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354 [TBL] [Abstract][Full Text] [Related]
4. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance. Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174 [TBL] [Abstract][Full Text] [Related]
5. Cancer network activity associated with therapeutic response and synergism. Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures. Li Y; Sahni N; Yi S Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma. Yellapu NK; Pulaganti M; Pakala SB J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030 [TBL] [Abstract][Full Text] [Related]
8. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis. Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801 [TBL] [Abstract][Full Text] [Related]
9. Gastric Cancer Cell Lines Have Different Maués JHDS; Ribeiro HF; Pinto GR; Lopes LO; Lamarão LM; Pessoa CMF; Moreira-Nunes CFA; de Carvalho RM; Assumpção PP; Rey JA; Burbano RMR Can J Gastroenterol Hepatol; 2018; 2018():5804376. PubMed ID: 30410872 [No Abstract] [Full Text] [Related]
10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
11. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures. Lee H; Kang S; Kim W PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019 [TBL] [Abstract][Full Text] [Related]
12. Conservation of immune gene signatures in solid tumors and prognostic implications. Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313 [TBL] [Abstract][Full Text] [Related]
13. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors. Glinsky GV Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database. Luo B; Gu YY; Wang XD; Chen G; Peng ZG Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049 [TBL] [Abstract][Full Text] [Related]
16. Identification of common gene networks responsive to radiotherapy in human cancer cells. Hou DL; Chen L; Liu B; Song LN; Fang T Cancer Gene Ther; 2014 Dec; 21(12):542-8. PubMed ID: 25412644 [TBL] [Abstract][Full Text] [Related]
17. Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer. Teschendorff AE; Li L; Yang Z Genome Biol; 2015 Apr; 16(1):61. PubMed ID: 25886003 [TBL] [Abstract][Full Text] [Related]
18. Bayesian Network to Infer Drug-Induced Apoptosis Circuits from Connectivity Map Data. Yu J; Silva JM Methods Mol Biol; 2018; 1783():361-378. PubMed ID: 29767372 [TBL] [Abstract][Full Text] [Related]
19. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis. Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105 [TBL] [Abstract][Full Text] [Related]
20. In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways. Cava C; Castiglioni I Gene; 2019 May; 698():100-106. PubMed ID: 30840853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]